Angus Australia and Vetoquinol to join forces
Angus Australia CEO, Dr Peter Parnell is delighted to announce a new partnership with independent global animal health company, Vetoquinol, in support of the Angus Sire Benchmarking Program (ASBP).
Family owned since 1963, Vetoquinol is the 9th largest veterinary pharmaceutical company in the world.
Originating from France, Vetoquinol has expanded its’ International Business Operations, serving to strengthen its portfolio of products globally. Vetoquinol’s growth and development strategy focuses on innovation.
“Vetoquinol’s growth and development strategy focuses on innovation. What better way for the company to facilitate this strategy by developing a partnership with Angus Australia”, said Dr Parnell.
The ASBP is a major initiative of Angus Australia with support from Meat & Livestock Australia (MLA) and industry partners such as Vetoquinol.
The major objectives of the ASBP include:
* Generate progeny test data on modern Angus bulls, particularly for hard to measure traits such as feed efficiency, abattoir carcase measurement, meat quality attributes & female reproduction.
* Generate data for the validation & refinement of Angus TACE.
* Build a comprehensive phenotype and genotype database on Australian Angus for genomic technology validation, research and development.
Vetoquinol will be responsible for supplying, through an appropriate veterinarian, the products required to conduct the fixed time artificial insemination program (FTAI) for Cohort 6 of the ASBP (i.e. current 2015 Joining program). This will include programming approximately 2,500 cows and inseminating with 42 Angus sires across seven co-operator herds.
Angus Australia Strategics Projects Manager, Christian Duff, believes that the partnership with Vetoquinol will continue to provide successful AI results.
“An effective fixed time AI program underpins the overall success of the ASBP through the number of effective progeny per sire produced. The Angus Australia partnership with Vetoquinol will ensure that the ASBP will continue with successful fixed time AI results. This is through the supply of products such as Cue-Mates and PREGNECOL, but most importantly the technical support and advice they can provide through their knowledgeable staff.”
Vetoquinol will also provide ongoing support through attendance at AI programs and full access to technical support for the duration of the partnership.
By choosing to partner with Angus Australia and the ASBP, Vetoquinol views this partnership as a means to add value to Vetoquinol and cattle producers alike.
“Vetoquinol Australia recognise the value of genetics for the Australian cattle industry. Angus Australia’s sire benchmarking project is a key venture to improve the genetic technologies and selection tools available to enable Australian cattle producers to get ahead. Vetoquinol Australia are the leading providers of artificial reproduction technologies, so this partnership provides Australian beef cattle producers what they need, not only high quality genetic selection tools but the ability to realise their investment in genetics by using artificial reproduction to elevate their herds to the next level”, says Dr Sophia Edwards, Technical Specialist – Reproduction, Australia & New Zealand for Vetoquinol Veterinary Pharmaceuticals.